152 related articles for article (PubMed ID: 38710949)
1. APOE4 homozygosity is a new genetic form of Alzheimer's disease.
Xu Q; Liang Z; Huang Y
Nat Med; 2024 May; 30(5):1241-1242. PubMed ID: 38710949
[No Abstract] [Full Text] [Related]
2. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
[TBL] [Abstract][Full Text] [Related]
3. NIH-funded research provides new clues on how ApoE4 affects Alzheimer's risk.
Am J Alzheimers Dis Other Demen; 2012 Aug; 27(5):356-7. PubMed ID: 22991704
[No Abstract] [Full Text] [Related]
4. Clinical Effects of Oral Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification.
Sabbagh MN
J Prev Alzheimers Dis; 2017; 4(3):136-137. PubMed ID: 29182703
[No Abstract] [Full Text] [Related]
5. Impaired memory-guided attention in asymptomatic APOE4 carriers.
Zimmermann J; Alain C; Butler C
Sci Rep; 2019 May; 9(1):8138. PubMed ID: 31148578
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction.
Ungar L; Altmann A; Greicius MD
Brain Imaging Behav; 2014 Jun; 8(2):262-73. PubMed ID: 24293121
[TBL] [Abstract][Full Text] [Related]
7. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
[TBL] [Abstract][Full Text] [Related]
8. Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification Potential.
Abushakra S; Porsteinsson A; Scheltens P; Sadowsky C; Vellas B; Cummings J; Gauthier S; Hey JA; Power A; Wang P; Shen L; Tolar M
J Prev Alzheimers Dis; 2017; 4(3):149-156. PubMed ID: 29182706
[TBL] [Abstract][Full Text] [Related]
9. ApoE4 May be a Promising Target for Treatment of Coronary Heart Disease and Alzheimer's Disease.
Chen W; Jin F; Cao G; Mei R; Wang Y; Long P; Wang X; Ge W
Curr Drug Targets; 2018; 19(9):1038-1044. PubMed ID: 29623835
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi003-A) and non-demented control (ASUi004-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant.
Brookhouser N; Zhang P; Caselli R; Kim JJ; Brafman DA
Stem Cell Res; 2017 Dec; 25():266-269. PubMed ID: 29246571
[TBL] [Abstract][Full Text] [Related]
11. ApoE genotype and family history in patients with dementia and cognitively intact spousal controls.
Zintl M; Schmitz G; Hajak G; Klünemann HH
Am J Alzheimers Dis Other Demen; 2009; 24(4):349-52. PubMed ID: 19372276
[TBL] [Abstract][Full Text] [Related]
12. APOE4 homozygote females are resistant to the beneficial effects of 17β-estradiol on memory and CA1 dendritic spine density in the EFAD mouse model of Alzheimer's disease.
Taxier LR; Philippi SM; Fleischer AW; York JM; LaDu MJ; Frick KM
Neurobiol Aging; 2022 Oct; 118():13-24. PubMed ID: 35843109
[TBL] [Abstract][Full Text] [Related]
13. Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease.
Huang Y
Trends Mol Med; 2010 Jun; 16(6):287-94. PubMed ID: 20537952
[TBL] [Abstract][Full Text] [Related]
14. One step closer to defining Alzheimer's causes. ApoE4 gene identified as possible target for drug therapy in Alzheimer's treatment.
Duke Med Health News; 2012 Aug; 18(8):6. PubMed ID: 23029675
[No Abstract] [Full Text] [Related]
15. Molecular Insight into the Therapeutic Promise of Targeting
Mamun AA; Uddin MS; Bin Bashar MF; Zaman S; Begum Y; Bulbul IJ; Islam MS; Sarwar MS; Mathew B; Amran MS; Md Ashraf G; Bin-Jumah MN; Mousa SA; Abdel-Daim MM
Oxid Med Cell Longev; 2020; 2020():5086250. PubMed ID: 32509144
[TBL] [Abstract][Full Text] [Related]
16. Early intervention in Alzheimer disease: The importance of APOE4 plus family history.
Corder EH; Caskey J
Neurology; 2009 Dec; 73(24):2054-5. PubMed ID: 20007523
[No Abstract] [Full Text] [Related]
17. A TAP2 genotype associated with Alzheimer's disease in APOE4 carriers.
Bullido MJ; Martínez-García A; Artiga MJ; Aldudo J; Sastre I; Gil P; Coria F; Muñoz DG; Hachinski V; Frank A; Valdivieso F
Neurobiol Aging; 2007 Apr; 28(4):519-23. PubMed ID: 16595160
[TBL] [Abstract][Full Text] [Related]
18. Disclosure of the genetic risk of Alzheimer's disease.
Gordon SC; Landa D
N Engl J Med; 2010 Jan; 362(2):181-2; author reply 182. PubMed ID: 20071713
[No Abstract] [Full Text] [Related]
19. Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: An N = 725 surface-based Alzheimer's disease neuroimaging initiative study.
Shi J; Leporé N; Gutman BA; Thompson PM; Baxter LC; Caselli RJ; Wang Y;
Hum Brain Mapp; 2014 Aug; 35(8):3903-18. PubMed ID: 24453132
[TBL] [Abstract][Full Text] [Related]
20. Precision Nutrition for Alzheimer's Prevention in
Norwitz NG; Saif N; Ariza IE; Isaacson RS
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33921683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
